2STEDMAN CA, BARCLAY ML. Review article:Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors [ J ]. Aliment Pharmacol Ther, 2000, 14: 963-978.
3SACHS G, SHIN JM, BRIVING C, et al. The pharmacology of the gastric acid pump: the H^+, K^+ ATPase [J]. Annu Rev Pharmacol Toxicol, 1995, 35:277 - 305.
4Johnstone D, Berger C, Fleckman P, et al. Acute ful minant hepattis after treatment with rabeprazole and tebinafine[J]. Arch Intern MM .2001.161 : 1677.
6Tytgat GNJ. Shortcomings of the first-generation proton pump inhibitors[J]. Eur J Gastroenterol Hapatol, 2001,13 (Suppl 1):29.
7Sachs G, Shin JM. The Pharmacology of the gastric acid pump.The H^+ , K^+ ATPase[J]. Annu Rev Phamacol Toxicol, 1995,35 : 277.
8Besancon M,Simon A,Sachs G, et al. Sites of reaction of the gastric H^+ , K ^+ ATPase with extraytoplasmic thiol regents[ J ]. J Biol Chen, 1997,272 : 22438.
9Carswell CI ,Goa KL. Rabeprazole. an update of its use in acid-related disorders[J]. Drugs ,2001,61:2327.
10LangtryHD,Markham A. Rabeprazole:a review of its use in acidrelated gastrointestinal disorders[J]. Drugs, 1999,58 : 725.
